Reply:

References

1. 1.↵
   1. Filippi M,
   2. Rocca MA

   . MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy. AJNR Am J Neuroradiol 2009 Dec 31 [Epub ahead of print]
2. 2.↵
   1. Geurts JJ,
   2. Bo L,
   3. Pouwels PJ,
   4. et al

   . Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005; 26: 572– 77

   Abstract/FREE Full Text
3. 3.↵
   1. Bendfeldt K,
   2. Radue EW,
   3. Borgwardt SJ,
   4. et al

   . Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis. J Neurol Sci 2009;285:268–69, author reply 69

   CrossRefPubMed
4. 4.↵
   1. Kutzelnigg A,
   2. Lucchinetti CF,
   3. Stadelmann C,
   4. et al

   . Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128:2705–12

   Abstract/FREE Full Text
5. 5.↵
   1. Bendfeldt K,
   2. Kuster P,
   3. Traud S,
   4. et al

   . Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis: a longitudinal voxel-based morphometry study. Neuroimage 2009;45:60–67

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Calabrese M,
   2. Rocca M,
   3. Atzori M,
   4. et al

   . A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 2010;67:376–83

   PubMedWeb of Science
7. 7.↵
   1. Calabrese M,
   2. Rocca MA,
   3. Atzori M,
   4. et al

   . Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology 2009;72:1330–36

   Abstract/FREE Full Text